Forget Fear: Why The FTSE 100 Can Still Yield Terrific Returns!

Royston Wild trawls the FTSE 100 (INDEXFTSE: UKX) to reveal an array of terrific stock stars.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Only the foolish would dare to speculate where the bottom lies for the FTSE 100, such is the degree of fear washing over global bourses at the current time.

There has certainly been plenty to test even the most bullish of stock pickers. Choose from further swathes of disappointing data from China; poor financial updates from the US, allied to concerns over the implications of Federal Reserve monetary tightening; and of course, the further downleg in commodity values.

These concerns have turned the FTSE 100 from something of a damp squib into a hazardous firecracker. The index fell 5% during the course of 2015 and has collapsed 7% since the turn of the year. This comes as little surprise however given the FTSE’s strong bias towards mining and commodity stocks, segments that are facing an increasingly-precarious outlook.

But I believe the FTSE’s prolonged sell-off can provide plenty of opportunities for savvy investors. As a broad rule, successful stock pickers tend to select companies with a view to holding them for a minimum of five years, and I believe there are plenty of stocks at the top of the London Stock Exchange whose long-term prospects remain extremely bright.

Housing heroes

Housebuilders like Taylor Wimpey (LSE: TW) and Barratt Developments (LSE: BDEV) were two of the FTSE 100’s strongest performers during the course of 2015, a backcloth of surging homebuyer demand and the enduring shortage of new homes entering the market driving values resoundingly higher.

Still, these shares have been washed-out by the wider malaise currently denting investor sentiment, and Taylor Wimpey and Barratt Developments have seen their values fall 12% and 10% respectively since the start of January.

But I believe this represents a fresh buying opportunity as house price growth shows no signs of slowing. Indeed, EY Item Club estimates that home values will advance a further 6.5% during 2015 alone.

Brand beauties

Elsewhere, I believe that selecting companies boasting stellar brand power is more important than ever as worsening economic pressures threaten to dent broader consumer spending activity.

With this in mind, I believe diversified manufacturer Unilever (LSE: ULVR) is a terrific defensive bet, a stock whose labels like Dove soap and VO5 shampoo command strong shopper loyalty. As such, the business enjoys robust revenue visibility, whatever the financial climate.

Unilever can afford to lift prices even as consumers’ wallets become lighter. Indeed, the London company continues to shrug cyclical woes in emerging markets, and saw sales in these regions rising 8.4% in July-September, accelerating from 6.5% in the prior quarter.

Fellow household goods leviathan Reckitt Benckiser (LSE: RB), along with drinks manufacturer Diageo (LSE: DGE) and cigarette giant Imperial Tobacco (LSE: IMT), also enjoy brilliant pricing power through their market-leading labels.

Medical marvels

Regardless of the impact of cyclical bumpiness in the global economy, medicine demand is of course one of life’s essentials, and I believe a backcloth of rising populations and galloping healthcare investment the world over should keep powering drugs growth higher in the years ahead.

FTSE 100 stalwarts GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN) have both thrown vast amounts of cash at reinventing their product pipelines, work that’s expected to put to bed the impact of crippling patent losses and drive earnings higher again in the next few years.

And investors should also keep an eye on Hikma Pharmaceuticals (LSE: HIK), a pharma play that (like GlaxoSmithKline and AstraZeneca) has invested heavily on bolt-on acquisitions to supercharge sales growth in developed and developing regions alike.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild owns shares of Barratt Developments. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended AstraZeneca, GlaxoSmithKline, and Hikma Pharmaceuticals. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

£5,000 of 9.2%-yielding Legal & General shares could make me £599 a month in passive income over time!

Legal and General shares remain a top passive income stock in my core portfolio holdings, with a 9.2% yield and…

Read more »

Investing Articles

With a 10.4% yield, P/E ratio of 9.9, and a P/B of 0.37, is this FTSE 100 stock a no-brainer buy for me?

Using a range of popular valuation measures, this FTSE 100 stock appears to offer tremendous value for money. So is…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Down nearly 18% from its 52-week high, is the Lloyds share price now a screaming buy for me?

In recent weeks, the Lloyds share price has under-performed the wider market. Could this be the buying opportunity that I’m…

Read more »

Investing Articles

As BAE Systems’ share price drops 14% should I buy more?

FTSE 100 defence giant BAE Systems recently reiterated strong growth guidance, leaving its share price looking significantly undervalued to me.

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

After an 18% jump on its 2024 results, is it too late for me to consider buying this FTSE 100 hidden gem?

This FTSE 100 technology firm unveiled very strong 2024 results recently and a big share buyback, but is it too…

Read more »

Investing Articles

£5,000 invested in Rolls-Royce shares in 2023 would have made this much by now

Rolls-Royce shares have been one of the best-performing UK FTSE 100 investments over the last two years. But how much…

Read more »

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

£5,000 invested in Lloyds shares in 2023 would be worth this much now

Lloyds shares and other banking stocks have thrived in 2024, but has it been a good investment for shareholders who…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

Why are investors blowing a raspberry at this FTSE 250 stock?

After a successful IPO, the share price of this FTSE 250 stock's fallen. Our writer looks at the reasons and…

Read more »